• Target：
• Cytokeratin 5/6

• Fields：
• >>Signal Transduction;>>Cytoskeleton / ECM;>>Cytoskeleton;>>Intermediate Filaments;>>Class I ;>>Cytokeratins

• Gene Name：
• KRT5 KRT6A KRT6B KRT6C

• Protein Name：
• Keratin； type II cytoskeletal 5 ；58 kDa cytokeratin；Cytokeratin-5；CK-5；Keratin-5；K5；Type-II keratin Kb5；type II cytoskeletal 6A;Cytokeratin-6A; CK-6A; Keratin-6A; K6A; Type-II keratin Kb6; allergen Ho

• Human Gene Id：
• 3852

• Human Swiss Prot No：
• P13647/P02538/P04259/P48668

• Immunogen：
• Synthesized peptide derived from human Cytokeratin 5 and Cytokeratin 6 AA range: C terminal amino acids 500-590 of Cytokeratin 5 and N terminal amino acids 2-100 of Cytokeratin 6

• Specificity：
• This product can specifically recognize human CK5 and CK6 protein.

• Formulation：
• Liquid in PBS containing 50% glycerol, and 0.05% Porcolin 300.

• Source：
• Monoclonal Mouse IgG2a, Kappa

• Dilution：
• Ready to use for IHC

• Purification：
• The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.

• Storage Stability：
• 2°C to 8°C/1 year

• Other Name：
• 58 kDa cytokeratin;CK-5;CK5;Cytokeratin-5;Cytokeratin5;DDD;DDD1;EBS2;epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types;K2C5_HUMAN;K5;keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types);Keratin 5;Keratin;keratin complex 2, basic, gene 5;keratin, type II cytoskeletal 5;Keratin-5;Keratin5;KRT 5;Krt5;KRT5A;type II cytoskeletal 5;Type-II keratin Kb5;CK 6A;CK 6B;CK 6C;CK 6D;CK 6E;CK-6B;CK-6C;CK-6E;Cytokeratin 6a;Cytokeratin 6B;Cytokeratin 6C;Cytokeratin 6D;Cytokeratin 6E;Cytokeratin-6B;Cytokeratin-6C;Cytokeratin-6E;K2C6C_HUMAN;K6a keratin;K6b keratin;K6C;K6c keratin;K6d keratin;K6e keratin;Keratin;Keratin K6h;Keratin type II cytoskeletal 6A;Keratin type II cytoskeletal 6B;Keratin type II cytoskeletal 6C;Keratin type II cytoskeletal 6D;Keratin type II cytoskeletal 6E;Keratin-6C;KRT6A;KRT6B;KRT6C;KRT6D;KRT6E;type II cytoskeletal 6C;Type-II keratin Kb12；58 kDa cytokeratin antibody;CK-5 antibody;CK5 antibody;Cytokeratin-5 antibody;Cytokera

• Background：
• Keratins are a large family of proteins that form the intermediate filament cytoskeleton of epithelial cells, which are classified into two major sequence types. Type I keratins are a group of acidic intermediate filament proteins, including K9-K23, and the hair keratins Ha1-Ha8. Type II keratins are the basic or neutral courterparts to the acidic type I keratins, including K1-K8, and the hair keratins, Hb1-Hb6. This antibody can react with Cytokeratin 5 and Cytokeratin 6.

• Function：
• function: Required for the formation of keratin intermediate filaments in the basal epidermis and maintenance of the skin barrier in response to mechanical stress (By similarity). Regulates the recruitment of Langerhans cells to the epidermis, potentially by modulation of the abundance of macrophage chemotactic cytokines, macrophage inflammatory cytokines and CTNND1 localization in keratinocytes (By similarity). Epidermis-specific type I keratin involved in wound healing. Involved in the activation of follicular keratinocytes after wounding, while it does not play a major role in keratinocyte proliferation or migration. Participates in the regulation of epithelial migration by inhibiting the activity of SRC during wound repair.

• Subcellular Location：
• Cytoplasmic, Membranous

• Expression：
• Expressed in corneal epithelium (at protein level).

• June 19-2018
• WESTERN IMMUNOBLOTTING PROTOCOL

• June 19-2018
• IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL

• June 19-2018
• IMMUNOFLUORESCENCE PROTOCOL

• September 08-2020
• FLOW-CYTOMEYRT-PROTOCOL

• May 20-2022
• Cell-Based ELISA│解您多样本WB检测之困扰

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN

• July 13-2018
• CELL-BASED-COLORIMETRIC-ELISA-PROTOCOL-FOR-TOTAL-PROTEIN

• July 13-2018
• Antibody-FAQs